Sei Investments Co. Has $88.18 Million Position in Icon Plc $ICLR

Sei Investments Co. boosted its holdings in Icon Plc (NASDAQ:ICLR) by 104.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 606,227 shares of the medical research company’s stock after buying an additional 309,635 shares during the quarter. Sei Investments Co.’s holdings in Icon were worth $88,176,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Artisan Partners Limited Partnership increased its position in Icon by 67.4% in the 2nd quarter. Artisan Partners Limited Partnership now owns 7,184,870 shares of the medical research company’s stock valued at $1,045,039,000 after acquiring an additional 2,893,946 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of Icon by 21.0% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,752,008 shares of the medical research company’s stock worth $545,730,000 after purchasing an additional 650,379 shares during the last quarter. Invesco Ltd. increased its holdings in Icon by 3.3% in the second quarter. Invesco Ltd. now owns 3,085,993 shares of the medical research company’s stock valued at $448,858,000 after purchasing an additional 98,032 shares during the period. Ninety One UK Ltd raised its position in Icon by 2.6% during the 2nd quarter. Ninety One UK Ltd now owns 2,993,652 shares of the medical research company’s stock worth $435,427,000 after purchasing an additional 75,465 shares during the last quarter. Finally, 1832 Asset Management L.P. lifted its holdings in Icon by 587.9% during the 2nd quarter. 1832 Asset Management L.P. now owns 1,151,328 shares of the medical research company’s stock worth $167,461,000 after buying an additional 983,950 shares during the period. 95.61% of the stock is owned by institutional investors.

Icon Price Performance

Shares of ICLR opened at $189.93 on Friday. Icon Plc has a 52-week low of $125.10 and a 52-week high of $228.29. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. The business’s 50 day moving average price is $176.65 and its two-hundred day moving average price is $166.03. The firm has a market cap of $15.34 billion, a PE ratio of 25.70, a price-to-earnings-growth ratio of 3.40 and a beta of 1.25.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Rothschild & Co Redburn raised Icon from a “neutral” rating to a “buy” rating and increased their price target for the company from $184.00 to $236.00 in a research note on Wednesday, September 3rd. Citigroup reiterated a “neutral” rating and issued a $200.00 target price (down from $225.00) on shares of Icon in a report on Thursday, August 21st. Robert W. Baird set a $220.00 target price on shares of Icon in a research report on Friday, October 24th. TD Cowen dropped their price target on shares of Icon from $183.00 to $172.00 and set a “hold” rating on the stock in a research report on Friday, October 24th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Icon in a research note on Monday, December 1st. Two equities research analysts have rated the stock with a Strong Buy rating, eight have assigned a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $205.00.

Icon Profile

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.